Drug shortages
HHS proposes policies to prevent drug shortages. Find out how AHA is collaborating with the private sector to mitigate supply chain vulnerabilities.
The Food and Drug Administration identified 39 new drug and biological product shortages in 2017, up from 26 in 2016, and 41 ongoing shortages from prior years, according to the agency’s latest annual report on the issue.
The American Medical Association today adopted a policy declaring drug shortages an urgent public health crisis.
The undersigned groups thank the Drug Enforcement Administration (DEA) for the opportunity to comment on its proposed rule regarding controlled substances quotas. Although we support DEA’s efforts to combat diversion, we are concerned that the proposed rule is focused on diversion to the exclusion…
We concur with the DEA that setting quotas for the production of opioid medications can be an effective step in “preventing the accumulation of controlled substances in amounts exceeding legitimate need,” and therefore reduce the chance that these powerful medications will be diverted for non-…
We thank President Obama for signing The Food and Drug Administration Safety and Innovation Act into law today. The number of drug shortages has tripled in the last six years and they are having an impact on patient care.
We applaud Congressional passage of the reauthorization of the Prescription Drug User Fee Act. The number of drug shortages has tripled in the last six years and the shortages have affected patient care.
AHA's Statement on President Obama's Executive Order on Drug Shortages.